Antigen expression patterns reflecting genotype of acute leukemias

被引:130
作者
Hrusák, O
Porwit-MacDonald, A
机构
[1] Charles Univ Prague, Inst Immunol, CLIP, Prague 15006 5, Czech Republic
[2] Karolinska Hosp & Inst, Dept Pathol, Stockholm, Sweden
关键词
leukemia; immunophenotype; cytogenetics; chromosomes; flow cytometry;
D O I
10.1038/sj.leu.2402504
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multi-parameter flow cytometry, molecular genetics, and cytogenetic studies have all contributed to new classification of leukemia. In this review we discuss immunophenotypic characteristics of major genotypic leukemia categories. We describe immunophenotype of: B-lineage ALL with MLL rearrangements, TEL/AML1, BCR/ABL, E2A/PBX1 translocations, hyperdiploidy, and myc fusion genes; T-ALL with SCL gene aberrations and t(5;14) translocation; and AML with AML1/ETO, PML/RARalpha, OTT/MAL and CBFbeta/MYH11 translocations, trisomies 8 or 11 and aberrations of chromosomes 7 and 5. Whereas some genotypes associate with certain immunophenotypic features, others can present with variable immunophenotype. Single molecules (as NG2, CBFbeta/SMMHC and PML/RARalpha proteins) associated with or derived from specific translocations have been described. More often, complex immunophenotype patterns have been related to the genotype categories. Most known associations between immunophenotype and genotype have been defined empirically. Therefore, these associations should be validated in independent patient cohorts before they can be widely used for prescreening of leukemia. Progress in our knowledge on leukemia will show how the molecular-genetic changes modulate the immunophenotype as well as how the expressed protein molecules further modulate cell behavior.
引用
收藏
页码:1233 / 1258
页数:26
相关论文
共 261 条
  • [1] ADRIAANSEN HJ, 1993, BLOOD, V81, P3043
  • [2] DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS
    ALTMAN, DG
    LAUSEN, B
    SAUERBREI, W
    SCHUMACHER, M
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (11) : 829 - 835
  • [3] Clinical significance of cytogenetic findings at diagnosis and in remission in childhood and adult acute lymphoblastic leukemia: Experience from India
    Amare, P
    Gladstone, B
    Varghese, C
    Pai, S
    Advani, S
    [J]. CANCER GENETICS AND CYTOGENETICS, 1999, 110 (01) : 44 - 53
  • [4] Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: Correlation with cytogenetics, morphology and immunophenotype
    Andrieu, V
    RadfordWeiss, I
    Troussard, X
    Chane, C
    Valensi, F
    Guesnu, M
    Haddad, E
    Viguier, F
    Dreyfus, F
    Varet, B
    Flandrin, G
    Macintyre, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (04) : 855 - 865
  • [5] APLAN PD, 1992, BLOOD, V79, P1327
  • [6] Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly:: confirmation of the existence of different entities with 11q23 breakpoint
    Archimbaud, E
    Charrin, C
    Magaud, JP
    Campos, L
    Thomas, X
    Fière, D
    Rimokh, R
    [J]. LEUKEMIA, 1998, 12 (01) : 25 - 33
  • [7] Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia
    Aricò, M
    Valsecchi, MG
    Camitta, B
    Schrappe, M
    Chessells, J
    Baruchel, A
    Gaynon, P
    Silverman, L
    Janka-Schaub, G
    Kamps, W
    Pui, CH
    Masera, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) : 998 - 1006
  • [8] AZUMA E, 1991, CANCER-AM CANCER SOC, V67, P1565, DOI 10.1002/1097-0142(19910315)67:6<1565::AID-CNCR2820670618>3.0.CO
  • [9] 2-K
  • [10] Acute myeloid leukemia with 11q23 translocations:: myelomonocytic immunophenotype by multiparameter flow cytometry
    Baer, MR
    Stewart, CC
    Lawrence, D
    Arthur, DC
    Mrózek, K
    Strout, MP
    Davey, FR
    Schiffer, CA
    Bloomfield, CD
    [J]. LEUKEMIA, 1998, 12 (03) : 317 - 325